Safety Study of Using Stem Cells to Stimulate Development of New Blood Vessels in Peripheral Vascular Disease
Status unconfirmed · Phase 1
Conditions studied: Peripheral Vascular Diseases
In brief
The purpose of this study is to determine if bone marrow derived adult stem cells are safe and effective in inducing development of new blood vessels (angiogenesis) in the legs of patients with severe peripheral vascular disease.
Key facts
- Study ID
- NCT00113243
- Run by
- Murphy, Michael P., MD
- People needed
- 20
- Starts
- 2004-12-01
- Expected to finish
- 2007-12-01
- Last updated by the study team
- 2005-06-24
Who can join
Age: 21 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Severe peripheral vascular disease not amenable to bypass or angioplasty
- Age >21 years old
- Normal renal function (creatinine < 1.6)
You may not qualify if…
- Congestive heart failure (ejection fraction [EF]<30%)
- History of cancer or myeloproliferative disorders
- Proliferative retinopathy
- Pregnancy
- Cognitively disabled
Where it is running
- Indiana University School of Medicine — Indianapolis, Indiana, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.